Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.2%

1 terminated out of 24 trials

Success Rate

93.8%

+7.2% vs benchmark

Late-Stage Pipeline

8%

2 trials in Phase 3/4

Results Transparency

20%

3 of 15 completed with results

Key Signals

3 with results94% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (5)
P 1 (1)
P 2 (4)
P 4 (2)

Trial Status

Completed15
Recruiting3
Not Yet Recruiting2
Active Not Recruiting2
Terminated1
Unknown1

Trial Success Rate

93.8%

Benchmark: 86.6%

Based on 15 completed trials

Clinical Trials (24)

Showing 20 of 20 trials
NCT07529756Not Yet Recruiting

The ReCAna for Lower ExtremIty Venous OBstructions and In-StEnt Restenosis Registry

NCT04304651Not ApplicableActive Not RecruitingPrimary

Screening for Occult Malignancy in Patients With Unprovoked Venous Thromboembolism

NCT04375982CompletedPrimary

Evaluation of the LumiraDx Point of Care D-Dimer and CRP Tests

NCT04263038Phase 4Recruiting

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

NCT05568966Not ApplicableRecruitingPrimary

Collection of Blood Samples for New Diagnostic Devices 2

NCT05907564Not ApplicableActive Not Recruiting

Aventus Thrombectomy System Pulmonary Embolism Clinical Study

NCT04657120Not ApplicableCompleted

Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With Malignancy

NCT06209892Not ApplicableNot Yet RecruitingPrimary

Prolonged Anticoagulation Therapy on the Prognosis of Patients With Left Ventricular Thrombosis

NCT05853796Recruiting

Observational Dutch Young Symptomatic StrokE studY - nEXT

NCT04439383Completed

Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients

NCT05128591Phase 1CompletedPrimary

A Study to Compare Pharmacokinetic Parameters and Safety Profiles Between AD-109 and AD-1091

NCT02610608Terminated

Medical Assistance for the Procreation and Risk of Thrombosis.

NCT04388657Unknown

COVID-19, bLOod Coagulation and Thrombosis

NCT04368377Phase 2Completed

Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19

NCT01203098Phase 2Completed

A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty

NCT01897103Completed

Platelet Activity in Vascular Surgery for Thrombosis and Bleeding

NCT02996851Completed

Traumatic Intracranial Hemorrhage in Users of Oral Antithrombotic Drugs

NCT00216866Phase 2CompletedPrimary

The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis

NCT02376777Completed

Comparison of Accidents and Their Circumstances With Oral Anticoagulants

NCT02720328Phase 4CompletedPrimary

Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants

Scroll to load more

Research Network

Activity Timeline